• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC ON-X ASCENDING AORTIC PROSTHESIS; MECHANICAL VALVE CONDUIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC ON-X ASCENDING AORTIC PROSTHESIS; MECHANICAL VALVE CONDUIT Back to Search Results
Model Number ONXAAP-23
Device Problem Insufficient Information (3190)
Patient Problems Complaint, Ill-Defined (2331); No Information (3190); No Code Available (3191)
Event Date 08/10/2016
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to the implant recovery card, patient implanted with onxaap-23 (b)(4) on (b)(6) 2016 which required explant on (b)(6) 2016 and replacement with another onxaap-23 as well as placement of a onxm-27/29.
 
Manufacturer Narrative
According to the implant registration cards (irc) submitted on 08/18/2016, a patient was implanted with an ascending aortic prosthesis (onxaap-23, sn (b)(4)) on (b)(6) 2016 which required explant on (b)(6) 2016 and replacement with another onxaap-23.Operative notes were received.Indications for reoperation include "mitral and aorotic valve prosthetic endocarditis in aortico-mitral curtain abscess, pseudoaneurysm, tricuspid valve, annuloplasty ring abscess and pacing wire abscess, endocarditis" performed via "mitral, aortic valve replacement, reconstruction of curtain, tricuspid valvuloplasty, closure aortic-ra fistula axillary cannulation and repair, redo, removal 8 sternal wires, removal of pacing wires and generator." the manufacturing records for the onxaap-23, sn (b)(4), were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation, no non-conformances or deviations were noted.The onxaap-23 was implanted (b)(6) 2016 and was explanted and replaced (b)(6) 2016 (0.54 years postoperatively).The reoperative report clearly states cause of failure is extensive endocarditis to the point that "the valve was being held essentially by two stitches." operated valve endocarditis is a recognized risk of prosthetic valves that could lead to thrombosis, thrombotic embolism, bleeding events, or paravalvular leak [akins 2008].The objective performance criteria of iso 5840 for rigid prosthetic valves indicates an endocarditis rate of (b)(4) pt-yr.In the proact study for avr, there were (b)(4) reported cases out of (b)(4) implants [puskas 2014].Deterioration of annular tissue due to extensive endocarditis led to insecure attachment of the valve to the heart.
 
Event Description
According to the implant recovery card, patient implanted with onxaap-23 ((b)(4)) on (b)(6) 2016 which required explant on (b)(6) 2016 and replacement with another onxaap-23 as well as placement of a onxm-27/29.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-X ASCENDING AORTIC PROSTHESIS
Type of Device
MECHANICAL VALVE CONDUIT
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC
1300 e. anderson ln.
bldg b
austin TX 78752
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer Contact
rochelle maney
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key5910860
MDR Text Key53390919
Report Number1649833-2016-00045
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date07/01/2019
Device Model NumberONXAAP-23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received08/18/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age36 YR
-
-